#Vascular Graft Market size

[market-insider]

Vascular Grafts Market Boosted By Rising Number Of Chronic Kidney Diseases, Heart Attacks And Atherosclerotic Heart Diseases

The global vascular grafts market size is anticipated to reach USD 3.1 billion by 2030 and is expected to expand at a CAGR of 7.0% during the forecast period, according to a new report by Grand View Research, Inc. The rising number of dialysis procedures and prevalence of chronic kidney diseases, heart attacks, atherosclerotic heart diseases, and stroke is boosting the adoption of vascular grafts. Moreover, the rising demand for minimally invasive surgeries among the population is impelling the market growth.

Furthermore, the increasing medical applications and developments in intraoperative techniques are driving the market. Peripheral vascular disease affects more than 200 million people worldwide. This is anticipated to raise the demand for vascular grafts during the forecast period. The outbreak of COVID-19 had a negative impact on the market growth due to the deferrals in non-essential medical procedures. It also affected the sales and operation of companies.

Gain deeper insights on the market and receive your free copy with TOC now @: Vascular Grafts Market Report

In 2021, the endovascular stent-graft products segment dominated the market with a revenue share of 63.8% due to its increasing adoption in response to the rising cases of aortic aneurysms. According to the data published by CDC, in 2019, about 9,904 deaths were witnessed due to aortic aneurysms in the United States. An unhealthy lifestyle has raised the prevalence of cardiac diseases and renal disease, thereby impelling the market growth.

Additionally, the increasing geriatric population and rising disposable income coupled with healthcare expenditure in emerging countries is contributing to market growth in these regions. The peripheral vascular grafts segment is expected to grow at the fastest rate due to increasing use in peripheral artery bypass. Also, the rising cases of hardening of arteries is boosting the demand for peripheral vascular graft.

The cardiac aneurysm application segment held the majority share in 2021 owing to the rising cases of raised blood pressure, hyperglycemia, hypercholesterolemia, etc. Also, the rising geriatric population and increasing cases of atherosclerotic heart diseases among the population are impelling the market growth. Moreover, the shifting trend toward minimally invasive treatments has raised the adoption of minimally invasive vascular implants to treat cardiac aneurysms, thereby boosting the segment growth.

On the other hand, the vascular occlusion application segment is anticipated to witness the fastest growth rate due to the increasing prevalence of vascular occlusion disease and the availability of graft procedures. Moreover, the development of novel therapies to treat vascular occlusion is anticipated to drive the market during the forecast period.

As of 2021, the polytetrafluoroethylene raw material segment held the majority share in the market and is expected to witness the fastest growth rate during the forecast period. The growth is attributed to its capability of tolerating pressures and flows in large and medium arteries; moreover, it offers low degradation and infection risk.     The key players offering innovative products that offer maximum protection and help reduce the pain is impelling the market growth. For instance, Biovic offers AVATAR PTFE Vascular Graft. It is developed using Humidity Resistant Technology and has porous microstructure on both internal and external surfaces to maximize tissue in-growth and healing response.

[marketsndata]

Global Vascular Access Devices Market Assessment 2031

Global vascular access devices market is projected to witness a CAGR of 5.83% during the forecast period 2024-2031, growing from USD 3.63 billion in 2023 to USD 5.71 billion in 2031. With increasing disease burden, rising hospitalization, and an improved healthcare system, the market of vascular access devices is anticipated to expand at a notable pace during the forecast period.

Vascular access devices are insertions used to administer drugs, fluids, blood, and nutrients in blood vessels. These devices include peripherally inserted central catheters (PICCs), central venous catheters, implantable ports, and peripheral intravenous catheters (PIVCs). With the never-ending evolution of healthcare services and medical devices, vascular access devices have evolved in terms of design, material, and integration of imaging technologies in it. Advancements in vascular access devices have improved biocompatibility, flexibility, and the adoption of novel materials, enhancing patient outcomes and quality of life. The rising demand for vascular access devices is driven by the growing burden of lifestyle diseases, technological advancements, and the need for minimally invasive procedures. Manufacturers are consistently working to enhance device design and materials to improve patient outcomes and reduce complications.

For instance, in May 2024, Teleflex Incorporated launched the Arrow EZ-IO Intraosseous Access Procedure Tray, enhancing its intraosseous vascular access portfolio. It includes all necessary components for intraosseous access, featuring the first FDA-cleared battery-powered driver that can be utilized in sterile environments. The tray is designed for quick and precise insertion, addressing the challenges clinicians face in obtaining vascular access during emergencies. However, risks associated with long-term use of catheters, such as infections and sepsis may pose challenges for market growth.

Rising Burden of Chronic Diseases to Increase the Market Size

The chronic disease burden is on a rise globally, owing to the increasing prevalence of chronic diseases, such as cancer, cardiovascular and urological disorders, and others, which necessitates frequent and long-term vascular access for treatments such as chemotherapy, dialysis, and medication administration, thereby driving the demand for various types of vascular access devices, including central venous catheters and peripheral IV catheters. Another factor contributing to the growing burden is the rising geriatric population, highly prone to catching such diseases. With the ongoing scenario, the future demand for vascular access devices is anticipated to increase further.

For instance, the National Institute of Health (NIH), anticipates that the number of adults 50 years and older suffer from at least one chronic disease, which will increase by 99.5% from 71.522 million in 2020 to 142.66 million in 2050. An estimated 48 million people, or 47% of all deaths globally, are expected to die from severe health-related suffering by 2060, an 87% increase from 26 million in 2016. It is anticipated that 83% of these deaths will occur in low and middle-income countries. As per World Health Organization (WHO) estimates, by 2050, there will be twice as many people 60 years or older on the planet with the population of 2.1 billion.

Design Improvements to Drive Market Demand

The established types of vascular access devices include central venous catheters (CVCs), arteriovenous fistulas (AVFs), and arteriovenous grafts (AVGs). Innovations in CVC tip and coating design have improved patency and blood flow rates. AVFs are preferred over CVCs as they are less prone to clotting and infection while providing reliable and adequate blood flow rates. With such design enhancements, the AVF creation devices have significant traction leading to market growth. Market players are taking chances to launch innovative products with enhanced designs. For instance, in September 2023, Laminate Medical Technologies announced that it received US-FDA clearance for its VasQ External Vascular Support device, designed to create AVFs for dialysis access. Notably, 80% of patients in trials using VasQ were able to remove central venous catheters within their first year of treatment, reducing the risk of infection compared to traditional AVFs. The VasQ device provides structural reinforcement to the vessels during AVF creation, promoting better arterial flow and functionality.

Drug Administration Application to Dominate Vascular Access Devices Market Share

The drug administration application of the vascular access devices market is anticipated to cover the highest market share. As these devices provide reliable, long-term access to the bloodstream, which is essential for patients needing frequent or prolonged intravenous therapies, such as chemotherapy or chronic disease management, reducing complications associated with traditional IV lines, such as infections and vein irritation, by minimizing the need for repeated needle sticks. A recent study published in the British Medical Journal in July 2024 examined the effectiveness of vascular access devices (VADs) in reducing infection rates among hospitalized patients. The study concluded that VADs along with specific safety measures reduce the chances of infection.

Download Free Sample Report

North America Dominates the Global Vascular Access Devices Market Share

North America is anticipated to hold major market share of the global vascular access devices market. North America’s leadership in the demand for vascular access devices is attributed to its advanced healthcare infrastructure, rising prevalence of chronic diseases, technological innovations, supportive regulations, and demographic trends favoring increased healthcare needs. According to the United States Renal Data System 2023 Annual Data Report, published in April 2024, more than 85% of individuals who began hemodialysis used a catheter. Additionally, nearly three-quarters of the United States population started without permanent access, a significant increase from about 65% in 2018. This rise in number clearly shows an increasing consumption of such devices in North America causing it to hold the largest market share among other regions.

Future Market Scenario (2024 – 2031F)

The vascular access devices market has witnessed several remarkable futuristic advancements that are anticipated to shape the future of such devices. These advancements include wearable technology, remote monitoring of atrioventricular flow, use of biocompatible materials for product design, 3D printing technology, image-guided vascular access devices, and others. The USFDA approval of WavelinQ and Ellipsys, two vascular access devices that facilitate the creation of arteriovenous fistulas (AVFs) using minimally invasive techniques has paved a new path for more products in line with endovascular fistula creation. The of the most revolutionary advancement is the image-guided vascular access system, Ultreon 1.0 launched by Abbott in October 2023. This platform uses near-infrared light to provide high-definition, precise imaging from within the blood vessels, allowing the healthcare professional precise access to blood vessels even in the most complex anatomies.

Report Scope

“Vascular Access Devices Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global vascular access devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Click here for full report- https://www.marketsandata.com/industry-reports/vascular-access-devices-market

Latest reports-

Contact

Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: info@marketsandata.com Website: https://www.marketsandata.com

[stanleyhuds]

Vascular Grafts Market Size, Share, Demand, Growth, and Forecast 2025-2033

Global Vascular Grafts Industry: Key Statistics and Insights in 2025-2033

Summary:

The global vascular grafts market size reached USD 2.0 Billion in 2024.

The market is expected to reach 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033.

North America leads the market, accounting for the largest vascular grafts market share.

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

The ongoing technological advancements in graft materials and design are supporting the market growth.

The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth.

Industry Trends and Drivers:

Prevalence of Cardiovascular Diseases:

The rising global cases of cardiovascular diseases (CVDs) are boosting market growth. These diseases often need surgery that uses vascular grafts.

Technological Advancements in Graft Materials and Design:

Technological progress in graft materials and designs is boosting the market. Today's vascular grafts are biocompatible, durable, and reduce complications like infections and rejection. Innovations such as drug-eluting and tissue-engineered grafts are also emerging. These grafts aim to better integrate with the body's tissues. Such advancements improve the safety and effectiveness of vascular surgeries, thus enhancing patient outcomes.

Preference for Minimally Invasive Surgeries (MIS):

Minimally invasive surgeries (MIS) are driving market growth. Procedures like endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) are less invasive than traditional surgeries. They also reduce hospital stays, lower infection risks, and speed up recovery. This boosts interest in specialized vascular grafts for these surgeries. Moreover, patients and doctors are leaning towards MIS for its benefits. This trend increases the demand for compatible vascular grafts.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

By Product:

Endovascular Stent Grafts

Hemodialysis Access Grafts

Coronary Artery By-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

Polytetrafluoroethylene (PTFE)

Polyester

Polyurethane

Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

Cardiac Aneurysm

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

Hospitals

Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

North America (United States, Canada)

Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America (Brazil, Mexico, Others)

Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Top Vascular Grafts Market Leaders: 

Abbott Laboratories

B. Braun SE (B. Braun Holding GmbH & Co. KG)

Becton, Dickinson & Company

Cook Group Incorporated

Cordis

CryoLife Inc.

Getinge AB

Heat Medical Europe BV

LeMaitre Vascular

Medtronic plc

Terumo Corporation

W.L. Gore & Associates Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 

[stevenwilliam12]

Rising Demand for Cancer Cachexia Treatments: Market Insights and Forecasts Through 2032

Cancer cachexia is a complex syndrome characterized by severe weight loss, muscle wasting, and a decline in physical function, significantly impacting the quality of life for cancer patients, particularly in advanced stages. This condition complicates cancer treatment efficacy, highlighting the urgent need for effective therapeutic options, which are currently limited.

Market Overview for Cancer Cachexia

The market for cancer cachexia is poised for significant growth by 2032, driven by the global rise in cancer incidence and the increasing recognition of cachexia as a serious medical condition. As cancer rates continue to rise, so does the prevalence of cancer cachexia, creating a critical area of unmet medical need within oncology.

Key Players in the Cancer Cachexia Market

Several companies are actively engaged in developing therapies for cancer cachexia, including:

AEterna Zentaris

Aphios Corporation

Artelo BIOSCIENCES

Caelus Health

Cannabics Pharmaceuticals

Helsinn Therapeutics

Ildong Pharmaceutical

Incyte Corporation

Janssen Pharmaceutical

NGM Biopharmaceuticals

Ono Pharmaceutical

PsiOxus Therapeutics

Smartfish AS

Tetra Biopharma

Epidemiology of Cancer Cachexia

Cancer cachexia is notably prevalent among patients with advanced-stage cancers, such as pancreatic, lung, and gastrointestinal cancers. According to DelveInsight's analysis, approximately 30-50% of cancer patients experience some degree of cachexia, with the highest rates observed in patients with aggressive malignancies. In the 7MM (United States, EU4, and Japan), over 1.5 million diagnosed prevalent cases of cancer cachexia were estimated in 2023. The incidence of this condition is expected to rise over the next decade due to factors such as aging populations and increasing cancer prevalence.

Competitive Landscape

Despite the competitive nature of the cancer cachexia market, it remains underdeveloped regarding available treatments. Leading pharmaceutical companies are exploring various therapeutic strategies, including appetite stimulants, anti-inflammatory drugs, and anabolic agents. Although advancements in research are being made, no universally effective treatment for all patients has been established. Several therapies are in the pipeline, focusing on novel combinations of medications that aim to alleviate both the symptoms and underlying causes of cancer cachexia.

Market Forecast

The cancer cachexia market is projected to expand rapidly by 2032. A growing understanding of the syndrome's impact on cancer progression and patient outcomes is anticipated to drive market growth. Additionally, regulatory authorities are increasingly fast-tracking the approval of promising treatments, which will facilitate the entry of more drug candidates into clinical trials, significantly enhancing the market's size and scope.

Conclusion

In conclusion, the cancer cachexia treatment market remains a vital area for therapeutic intervention, with substantial growth potential expected in the coming decade. The need for effective treatments and the ongoing research efforts in this field underscore its importance in improving the quality of life for cancer patients.

Latest Reports Offered By DeveInsight:

Vascular Graft Devices Market | Vascular Stents Market | Extracorporeal Membrane Oxygenation Devices Market | Fallopian Tube Cancer Market | Physiotherapy Equipment Market | Postoperative Nausea And Vomiting Market | Relapsing Multiple Sclerosis Market | Respiratory Distress Syndrome Market | Interspinous Spacers Market | Resorbable Vascular Scaffold Market | Smart Inhalers Market | Diverticulosis Market | Fenebrutinib Market | Indolent Lymphoma Market | Optic Neuropathy Market | Tbi Market | Trastuzumab Market | Urinary Incontinence Market | Cytomegalovirus Infections Market | Dense Deposit Disease Market | Diabetic Eye Disease Market | Gestational Diabetes Market | Panuveitis Market | Type 2 Diabetes Market | Advanced Wound Care Market

[farmacuticals]

Competitive Landscape and Major Players in the Global Cardiovascular Prosthetic Device Market

Cardiovascular prosthetic devices are specialized medical implants designed to support or replace damaged heart valves, arteries, or other components of the cardiovascular system. These devices play a critical role in the treatment of heart-related conditions, helping improve the quality of life for patients suffering from diseases such as coronary artery disease, heart failure, and valvular heart disease. Common cardiovascular prosthetic devices include artificial heart valves, vascular grafts, stents, and pacemakers.

The Cardiovascular Prosthetic Device Market Size was projected by MRFR research to reach 67.49 (USD Billion) by 2022. It is anticipated that the market for cardiovascular prosthetic devices would increase from 70.68 billion USD in 2023 to 107.2 billion USD in 2032. Over the projected period (2024 - 2032), the Cardiovascular Prosthetic Device Market is expected to develop at a compound annual growth rate (CAGR) of about 4.73%.

The demand for cardiovascular prosthetic devices is driven by the increasing prevalence of cardiovascular diseases worldwide, attributed to factors such as aging populations, sedentary lifestyles, and unhealthy diets. These devices have significantly evolved, with advancements in biocompatible materials, minimally invasive surgical techniques, and improved long-term performance, contributing to better patient outcomes.

Cardiovascular Prosthetic Device Size

The market size for cardiovascular prosthetic devices is substantial and continues to grow at a rapid pace. In 2023, the global cardiovascular prosthetic device market was valued at several billion dollars and is projected to maintain a steady growth rate over the coming years. This growth is fueled by the rising incidence of heart diseases, increasing healthcare spending, and the adoption of advanced medical technologies.

The market is segmented into different types of cardiovascular prosthetic devices, such as heart valves, stents, pacemakers, and ventricular assist devices (VADs). Each segment has its own market size, with heart valves and stents being among the most dominant segments due to their high demand in the treatment of valve disorders and coronary artery diseases. Furthermore, the advent of minimally invasive procedures like transcatheter aortic valve replacement (TAVR) has expanded the market by offering alternatives to traditional open-heart surgery.

Cardiovascular Prosthetic Device Market Share

The cardiovascular prosthetic device market is highly competitive, with several leading companies holding significant market share. Key players include Medtronic, Abbott Laboratories, Edwards Lifesciences, and Boston Scientific. These companies are constantly investing in research and development to introduce innovative products that address unmet medical needs.

Medtronic, for instance, holds a major market share due to its wide range of cardiovascular prosthetic devices, including artificial heart valves and stents. Edwards Lifesciences is a leading player in the heart valve segment, particularly with its transcatheter heart valve products. Abbott Laboratories and Boston Scientific are also strong contenders in the stent and pacemaker markets.

Cardiovascular Prosthetic Device Trends

Several trends are shaping the cardiovascular prosthetic device market, including:

Minimally Invasive Surgeries: There is a growing preference for minimally invasive procedures such as TAVR and transcatheter mitral valve replacement (TMVR), which reduce recovery times and surgical risks for patients.

Biodegradable Stents: The development of bioresorbable stents is revolutionizing coronary artery treatment. These stents dissolve naturally after performing their function, reducing the risk of long-term complications.

Smart Implants: Technological advancements are driving the creation of smart cardiovascular prosthetic devices, such as pacemakers with remote monitoring capabilities, allowing real-time tracking of patient health.

Aging Population: With the aging global population, the demand for cardiovascular prosthetic devices is expected to increase, as elderly individuals are more prone to heart diseases.

Emerging Markets: The cardiovascular prosthetic device market is experiencing growth in emerging economies due to improving healthcare infrastructure, increased awareness, and rising healthcare spending.

Reasons to Buy the Reports

In-Depth Market Analysis: A comprehensive understanding of the current cardiovascular prosthetic device market size, share, and growth trends.

Competitive Landscape: Insights into key players, their market strategies, and the latest product innovations.

Future Market Projections: Detailed forecasts of the market growth and the factors influencing this expansion.

Technological Advancements: Information on the latest technological developments in cardiovascular prosthetic devices and how they are improving patient outcomes.

Regulatory Insights: Key regulatory guidelines and approvals that influence the cardiovascular prosthetic device market, ensuring compliance and market access.

Recent Developments in Cardiovascular Prosthetic Devices

Recent developments in the cardiovascular prosthetic device market include the introduction of next-generation transcatheter valves, bioresorbable stents, and advanced pacemakers with enhanced battery life and wireless connectivity. Moreover, collaborations between medical device companies and research institutions are leading to innovations in the design and functionality of prosthetic devices, focusing on improving patient safety and treatment efficacy. These advancements are expected to drive the growth of the cardiovascular prosthetic device market in the coming years.

Related Report:

Medical Clothing Market

Medical Kiosk Market

Molecular Quality Control Market

[credenceresearchdotblog]

The Vascular Grafts Market is projected to grow from USD 1,263.48 million in 2023 to an estimated USD 2,422.39 million by 2032, with a compound annual growth rate (CAGR) of 7.50% from 2024 to 2032. The global vascular grafts market has seen significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases, the aging population, and advancements in medical technology. Vascular grafts are used in surgical procedures to bypass, repair, or replace damaged blood vessels, making them a crucial component in the treatment of various vascular conditions. These grafts can be synthetic, biological, or composite, depending on the material used, and they play a critical role in procedures such as coronary artery bypass surgery, peripheral artery disease treatment, and hemodialysis access.

Browse the full report at https://www.credenceresearch.com/report/vascular-grafts-market

Market Overview

As of 2024, the vascular grafts market is experiencing a robust growth trajectory, with a market value that is expected to reach billions of dollars in the coming years. The demand for vascular grafts is fueled by the increasing burden of cardiovascular diseases, which are among the leading causes of death globally. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) claim over 17 million lives annually, and this number is expected to rise due to factors such as unhealthy lifestyles, rising obesity rates, and an aging population.

The market is segmented based on product type, application, and end-user. The main types of vascular grafts include:

1. Endovascular Stent Grafts – Used in minimally invasive procedures to treat aneurysms or occluded blood vessels. 2. Peripheral Vascular Grafts – Typically used to bypass or replace damaged vessels in the peripheral arterial system. 3. Hemodialysis Access Grafts – Commonly used to create arteriovenous (AV) fistulas for patients undergoing dialysis.

Key Drivers of Market Growth

1. Rising Prevalence of Cardiovascular Diseases The increasing incidence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, is the primary driver of the vascular grafts market. As lifestyles become more sedentary, coupled with poor dietary habits and rising levels of obesity, the demand for cardiovascular procedures such as coronary artery bypass grafting (CABG) is rising.

2. Aging Population The global population is aging, and older adults are more prone to cardiovascular diseases, atherosclerosis, and related complications. This demographic trend is a major factor contributing to the growth of the vascular grafts market. Elderly individuals often require vascular grafts in procedures such as aneurysm repair or dialysis access creation, which boosts demand.

3. Technological Advancements The development of new materials and technologies for vascular grafts has significantly enhanced their performance and outcomes. For instance, the introduction of bioengineered grafts and hybrid materials that combine synthetic and biological properties has improved the compatibility and durability of grafts. Furthermore, advancements in endovascular procedures, which are less invasive than traditional open surgeries, have driven the adoption of vascular grafts, particularly stent grafts.

4. Increasing Incidence of End-Stage Renal Disease (ESRD) The rising prevalence of diabetes and hypertension has contributed to a growing number of patients with end-stage renal disease (ESRD). These patients require hemodialysis, and vascular grafts are often used to create AV fistulas for dialysis access. As the incidence of ESRD increases, so does the demand for vascular grafts, particularly in the healthcare sector of developed countries.

Challenges Facing the Market

Despite the promising growth, the vascular grafts market faces several challenges. One major concern is the risk of graft failure due to infection, thrombosis, or rejection. While advances in material science have improved the performance of grafts, complications still arise, particularly in high-risk patients. Additionally, the cost of vascular grafts and associated procedures can be prohibitive for patients in low- and middle-income countries, limiting access to these life-saving interventions.

Another challenge is the stringent regulatory environment that governs the approval and commercialization of vascular grafts. Medical devices, especially those used in critical procedures, are subject to rigorous testing and approval processes. This can delay the introduction of new products to the market.

Regional Insights

The vascular grafts market is segmented by region, with North America, Europe, Asia-Pacific, and the Rest of the World (RoW) being key markets. North America holds the largest share of the market, driven by the high prevalence of cardiovascular diseases, a well-established healthcare system, and the presence of leading medical device manufacturers. Europe follows closely behind, with a similar disease burden and strong healthcare infrastructure.

In contrast, the Asia-Pacific region is expected to witness the fastest growth in the coming years, driven by the increasing healthcare expenditure, a growing middle class, and rising awareness of cardiovascular health. Countries such as China and India are seeing a surge in demand for vascular grafts due to the rising incidence of lifestyle-related diseases and improvements in healthcare accessibility.

Future Outlook

The future of the vascular grafts market looks promising, with continued growth expected due to ongoing advancements in medical technology, an aging population, and the increasing prevalence of cardiovascular diseases. Innovations in graft materials, such as the use of bioresorbable polymers and tissue-engineered grafts, will likely enhance the durability and success rates of vascular procedures.

Moreover, as healthcare systems in emerging economies improve, the demand for vascular grafts in these regions is expected to increase. Government initiatives aimed at improving cardiovascular health and expanding access to healthcare services will also play a crucial role in driving market growth.

Key players

Medtronic

Terumo Corporation

LeMaitre Vascular, Inc.

Getinge AB

BD (Becton Dickinson)

Abbott

Braun Melsungen AG

L. Gore and Associates, Inc.

MicroPort Scientific Corporation

Endologix

Segments

Based on product

Haemodialysis Access Grafts

Endovascular Stent Grafts

Coronary Artery Based on-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Based on application

Cardiac Aneurysm

Endovascular Stent Graft

Vascular Graft

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Others

Based on raw material

Synthetic Vascular Grafts

Polytetrafluoroethylene (PTFE) Grafts

Polyester Grafts,

Polyurethane Grafts

Biological Vascular Grafts

Autografts

Allografts

Xenografts

Hybrid Vascular Grafts

Based on region

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/vascular-grafts-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[pranalip]

Cardiovascular Devices Market – In Depth Insight Analysis to 2033 | Global Insight Services

“Global Insight Services offers unparalleled market intelligence and strategic consulting services to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition”.

The global cardiovascular devices market size was USD 53.3 billion in 2021 and is anticipated to reach USD 91.9 billion in 2031, growing at a rate of 5.2% from 2022 to 2031.

Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Cardiovascular devices such as stents, catheters, grafts, and others are used to treat CVDs efficiently.

View The Full Report Here –https://www.globalinsightservices.com/reports/cardiovascular-devices-market

Market Trends and Drivers

The cardiovascular devices control irregularities caused by the heart’s electrical systems, such as irregular heartbeat and heart rhythm disorders. When medication, lifestyle changes, or other treatments do not work, an implantable device may be recommended. Certain factors that are boosting the cardiovascular devices market growth include a rise in the use of ambulatory and home services for cardiac monitoring, the increasing prevalence of cardiovascular disorders, favorable reimbursement policies, and technological advancements.

Besides, the growth of the global cardiovascular devices market is also attributed to the growing demand for high-performance and efficient cardiovascular systems globally. Increasing awareness regarding the benefits of the cardiovascular devices market is expected to positively impact the revenue growth of the market over the forecast period. In addition, developments in cardiovascular devices positively contribute to the growth of the global cardiovascular devices market. Further, the rising demand for cardiovascular devices from emerging economies to treat patients suffering from cardiovascular devices effectively is expected to cater to the growth of the cardiovascular devices industry. Besides, the rise in the number of hospitals in addition to small and medium-sized companies is increasing the demand for cardiovascular devices. Furthermore, technological advancements in cardiovascular devices are anticipated to offer lucrative opportunities for the market players.

Market Restraints & Challenges

One of the major factors hindering the global cardiovascular devices market growth is the stringent regulatory requirements that delay the approval of cardiac devices. In addition, the other concern & risk connected to the market is that the therapeutic radiation used in cancer treatment affects the operation of a patient with implantable cardiac rhythm devices. This device uses complementary metal-oxide-semiconductor (CMOS) which are susceptible to damage by the therapeutic doses of radiation. This factor is one of the major factors that limits the scope of using cardiac devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. Besides, the high cost of these devices along with limited insurance coverage is restraining the growth of the market.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS20313

Market Segments

By Type

Diagnostic & Monitoring Devices

Therapeutic & Surgical Devices

By Application

Cardiac Rhythm Management & Heart Failure

Coronary Vascular

Structural Heart

Peripheral Vascular

Others

By End User

Hospitals

Specialty Centers

Major Players of the Global Cardiovascular devices Market

The global cardiovascular devices market report includes players such as Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cook Medical, Koninklijke Philips N.V., Medtronic plc., and Terumo Corporation.

Prominent players in the industry such as Abbott Laboratories, Boston Scientific Corp., and Medtronic plc. are focusing on adopting acquisition as their key developmental strategy to boost the product offerings of cardiovascular devices. For instance, in February 2022, Boston Scientific acquired Baylis Medical Company Inc., which offers advanced transseptal access solutions along with guidewires, sheaths, and dilators used to support catheter-based left-heart procedures.

COVID-19 Analysis:

According to the International Monetary Fund (IMF), due to the epidemic of a novel coronavirus, the worldwide economy decreased by over 3.0% in 2020. Several nations were under strict lockdowns in 2020 & 2021, which have impacted the supply of raw materials. Therefore, due to this, the manufacturing activities of cardiovascular device producers have ceased. While some cardiovascular procedures are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. The other aspect negatively affecting the market is the drop in the diagnosis of cardiovascular diseases owing to healthcare resources being reserved for COVID-19 patients. Besides, several medical device companies have suffered losses in their cardiovascular device businesses owing to the pandemic. To cite an instance, Medtronic plc announced a reduction of nearly one-third in its cardiac and vascular business sector in its 2020 quarterly financial results. Moreover, demand for cardiovascular devices from hospitals has been dropped amid their stopped operations, due to government-imposed lockdown measures. This is anticipated to hamper the cardiovascular devices market growth during the forecast period.

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS20313

 Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[pranalipawarshinde]

Cardiovascular Devices Market – Exclusive Report Study on the Current Trends And Forecast 2024-2033

“Global Insight Services offers unparalleled market intelligence and strategic consulting services to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition”.

The global cardiovascular devices market size was USD 53.3 billion in 2021 and is anticipated to reach USD 91.9 billion in 2031, growing at a rate of 5.2% from 2022 to 2031.

Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Cardiovascular devices such as stents, catheters, grafts, and others are used to treat CVDs efficiently.

View The Full Report Here –https://www.globalinsightservices.com/reports/cardiovascular-devices-market

Market Trends and Drivers

The cardiovascular devices control irregularities caused by the heart’s electrical systems, such as irregular heartbeat and heart rhythm disorders. When medication, lifestyle changes, or other treatments do not work, an implantable device may be recommended. Certain factors that are boosting the cardiovascular devices market growth include a rise in the use of ambulatory and home services for cardiac monitoring, the increasing prevalence of cardiovascular disorders, favorable reimbursement policies, and technological advancements.

Besides, the growth of the global cardiovascular devices market is also attributed to the growing demand for high-performance and efficient cardiovascular systems globally. Increasing awareness regarding the benefits of the cardiovascular devices market is expected to positively impact the revenue growth of the market over the forecast period. In addition, developments in cardiovascular devices positively contribute to the growth of the global cardiovascular devices market. Further, the rising demand for cardiovascular devices from emerging economies to treat patients suffering from cardiovascular devices effectively is expected to cater to the growth of the cardiovascular devices industry. Besides, the rise in the number of hospitals in addition to small and medium-sized companies is increasing the demand for cardiovascular devices. Furthermore, technological advancements in cardiovascular devices are anticipated to offer lucrative opportunities for the market players.

Market Restraints & Challenges

One of the major factors hindering the global cardiovascular devices market growth is the stringent regulatory requirements that delay the approval of cardiac devices. In addition, the other concern & risk connected to the market is that the therapeutic radiation used in cancer treatment affects the operation of a patient with implantable cardiac rhythm devices. This device uses complementary metal-oxide-semiconductor (CMOS) which are susceptible to damage by the therapeutic doses of radiation. This factor is one of the major factors that limits the scope of using cardiac devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. Besides, the high cost of these devices along with limited insurance coverage is restraining the growth of the market.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS20313

Market Segments

By Type

Diagnostic & Monitoring Devices

Therapeutic & Surgical Devices

By Application

Cardiac Rhythm Management & Heart Failure

Coronary Vascular

Structural Heart

Peripheral Vascular

Others

By End User

Hospitals

Specialty Centers

Major Players of the Global Cardiovascular devices Market

The global cardiovascular devices market report includes players such as Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cook Medical, Koninklijke Philips N.V., Medtronic plc., and Terumo Corporation.

Prominent players in the industry such as Abbott Laboratories, Boston Scientific Corp., and Medtronic plc. are focusing on adopting acquisition as their key developmental strategy to boost the product offerings of cardiovascular devices. For instance, in February 2022, Boston Scientific acquired Baylis Medical Company Inc., which offers advanced transseptal access solutions along with guidewires, sheaths, and dilators used to support catheter-based left-heart procedures.

COVID-19 Analysis:

According to the International Monetary Fund (IMF), due to the epidemic of a novel coronavirus, the worldwide economy decreased by over 3.0% in 2020. Several nations were under strict lockdowns in 2020 & 2021, which have impacted the supply of raw materials. Therefore, due to this, the manufacturing activities of cardiovascular device producers have ceased. While some cardiovascular procedures are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. The other aspect negatively affecting the market is the drop in the diagnosis of cardiovascular diseases owing to healthcare resources being reserved for COVID-19 patients. Besides, several medical device companies have suffered losses in their cardiovascular device businesses owing to the pandemic. To cite an instance, Medtronic plc announced a reduction of nearly one-third in its cardiac and vascular business sector in its 2020 quarterly financial results. Moreover, demand for cardiovascular devices from hospitals has been dropped amid their stopped operations, due to government-imposed lockdown measures. This is anticipated to hamper the cardiovascular devices market growth during the forecast period.

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS20313

 Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[wellnessweb]

Forecasting the Biomaterials  Market Size: Future Prospects

The Biomaterials Market size was estimated USD 156.1 billion in 2022 and is expected to reach USD 501.2 billion by 2030 at a CAGR of 15.7% during the forecast period of 2023-2030. The biomaterials market is experiencing rapid growth, driven by advancements in medical technology and increasing demand for innovative healthcare solutions. These materials, which include metals, ceramics, polymers, and natural substances, are pivotal in developing implants, prosthetics, and tissue engineering products. Their biocompatibility and functionality are enhancing the efficacy of medical treatments, particularly in orthopedics, cardiovascular applications, and wound care. The market is also benefiting from an aging global population and rising incidences of chronic diseases, which necessitate advanced medical interventions. Furthermore, ongoing research and development are fostering new applications and expanding the capabilities of biomaterials, positioning the market for sustained expansion and significant contributions to modern medicine.

Get Sample Of This Report @ https://www.snsinsider.com/sample-request/3791

Market Scope & Overview

The Biomaterials Market research analyses all industries in terms of demand estimations in various areas to give a cross-sectional perspective of the global economy. The study looks at a number of demand, restriction, and opportunity factors that are anticipated to have an immediate impact on market growth. For the purpose of assisting readers in evaluating the financial stability of important market participants, the study contains an analysis of the industry's competitiveness as well as a structural evaluation of Porter's Five Forces.

The Biomaterials Market research concentrates on the many chances, constraints, and expansions that are expected to have a direct influence on commercial outcomes. The research report will focus on new developments and cutting-edge technologies that will significantly affect the growth of the global market over the course of the projection year.

Market Segmentation Analysis

By Product

Metallic

Natural

Ceramics

Polymers

By Application

Cardiovascular

Sensors

Stents

Guidewires

Implantable Cardiac Defibrillators

Pacemakers

Vascular Grafts

Others

Ophthalmology

Synthetic Corneas

Intraocular Lens

Contact Lens

Ocular Tissue Replacement

Others

Dental

Tissue Regeneration Materials

Dental Implants

Bone Grafts & Substitutes

Dental Membranes

Others

Orthopedic

Joint Replacement Biomaterials

Orthobiologics

Bioresorbable Tissue Fixation Products

Viscosupplementation

Spine Biomaterials

Others

Wound Healing

Fracture Healing Device

Adhesion Barrier

Skin Substitutes

Internal Tissue Sealant

Surgical Hemostats

Others

Tissue Engineering

Plastic Surgery

Facial Wrinkle Treatment

Soft Tissue Fillers

Craniofacial Surgery

Bioengineered Skins

Peripheral Nerve Repair

Acellular Dermal Matrices

Others

Neurology

Neural Stem Cell Encapsulation

Shunting Systems

Hydrogel Scaffold for CNS Repair

Cortical Neural Prosthetics

Others

Others

COVID-19 Impact Analysis

In order to give clients correct information to address market challenges during and after COVID-19, various industry experts and delegates are interviewed for a report on the Biomaterials Market during the main and secondary research phases. The market research report may be used by suppliers, end users, and distributors to find answers to a variety of questions, plan acquisitions, and look for further business prospects. It examines potential solutions as well as present and upcoming difficulties.

Regional Outlook

The research comprises a SWOT analysis model evaluation and a regional market competition analysis to help consumers estimate the regional health of important global business suppliers. All significant geographic areas are covered by the Biomaterials Market analysis, including the Middle East and Africa, North America, Asia Pacific, and Europe.

Competitive Analysis

A global market report that takes into account definitions, classifications, implementations, and supply chain structure also offers a fundamental overview. Information on important market participants, production trends, industry environment analysis, and regional growth trends are just a few of the topics covered in the global Biomaterials Market share report. The research looks at production methods, price trends, and expansion and growth objectives, among other things.

Key Reasons to Purchase the Biomaterials Market Report

By comparing data from prior years, external validation of these segments and sub-segments was also carried out.

The research report includes a cross-section of the global economy as well as market analyses for each geographical location.

Conclusion

All key discoveries and technological advances that will significantly affect the global market over the forecasted time period will be covered in the Biomaterials Market research report.

Read Full Report @ https://www.snsinsider.com/reports/biomaterials-market-3791

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Forensic Technology Industry Trends

Functional Service Providers Industry Trends

Genome Editing Industry Trends

Genomics Services Industry Trends

Genotyping Industry Trends

[blueweave]

Endoscopic Vessel Harvesting Market size at USD 504.8 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects Global Endoscopic Vessel Harvesting Market size to grow at a CAGR of 3.58% reaching a value of USD 623.45 million by 2029. Major growth drivers for the Global Endoscopic Vessel Harvesting Marketinclude growing inclination toward minimally invasive harvesting procedures and the increasing prevalence of cardiovascular diseases. Notably, the expanding healthcare sector, a growing geriatric population across the regions, and increasing applications in emerging economies also contribute to the overall market growth. It is projected that by 2050, the worldwide number of individuals aged 65 years or above will surpass twice the number of children under the age of 5 and will be comparable to the number of children under the age of 12. Also, a study published in the Journal of Thoracic Disease in March 2021 revealed that patients undergoing minimally invasive vein or vessel harvesting were discharged four days earlier compared to those undergoing open harvesting procedures, indicating the growing advantages of minimally invasive harvesting methods that are expected to contribute to market growth. However, high cost of endoscopic vessel harvesting devices and reimbursement challenges are anticipated to restrain the overall market growth during the period in analysis.

Opportunity - Growing awareness of endoscopic vessel harvesting

The use of endoscopic vessel harvesting (EVH) devices is not limited to cardiac and vascular surgery but extends to other medical procedures like plastic surgery or organ transplantation. The diversification, as a result, broadens the market potential and clientele for EVH devices. Additionally, the incorporation of artificial intelligence (AI) in surgical optimization, including graft selection and procedural guidance, presents significant growth opportunities. The adoption of telemedicine and remote surgery can further propel market growth, enabling surgeons to perform procedures from remote locations. Collaborations with regenerative medicine open new avenues for applying harvested grafts in tissue engineering and organ transplantation. The integration of patient-specific data enhances the potential for individualized surgical approaches, contributing to improved transplant selection. Overall, the evolving awareness of the versatile applications of EVH devices signifies a growing understanding within the medical community, expanding their role beyond traditional surgical domains.

Sample Request @ https://www.blueweaveconsulting.com/report/endoscopic-vessel-harvesting-market/report-sample